Clinical trial · Observational
Active Surveillance of Papillary Thyroid Microcarcinoma
Active Surveillance of Papillary Thyroid Microcarcinoma (PTMC) in Catholic Medical Center
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Papillary thyroid microcarcinoma are small thyroid cancer measuring 1cm or less. Most of this tumor are not palpable and are identified either through pathologic examination or from imaging modalities, such as CT scan or thyroid sono. Active surveillance of papillary microcarcinoma is to observe thyroid papillary cancer without immediate surgical approach. The purpose of this study is to understand more about the characteristics of papillary microcarcinoma, which has been known for "the cancer slowly progression"
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Thyroid Cancer, Papillary | Thyroid Gland Papillary Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Progression of papillary thyroid microcarcinoma
- timeFrame
- 5 years after enrollment
- description
- Using thyroid sonography, check any changes in size and shape of papillary thyroid microcarcinoma
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. \< 1 cm solitary nodule 2. Surrounded by ≥ 2 mm normal thyroid parenchyma 3. Subcapsular locations not adjacent to surrounding structures, recurrent laryngeal nerve, trachea, or carotid artery 4. No evidence of invasion to surrounding structures, recurrent laryngeal nerve, trachea or carotid artery 5. No extrathyroidal extension 6. Clinically N0 and Clinically M0 7. ≥ 18 years 8. Combined severe comorbidities or Inoperable condition (optional) 9. No wish to surgery and Willingness to accept active surveillance 10. No history of radiotherapy on head and neck area 11. Accepted by the Board of Thyroid Cancer Meeting Exclusion Criteria: 1. ≥ 1 cm nodule and multifocal nodules regardless of size 2. Papillary thyroid carcinoma variants associated with poor prognosis (tall cell variant, columnar variant, hobnail variant) or other types of thyroid cancer) 3. Subcapsular locations adjacent to surrounding structures, recurrent laryngeal nerve, trachea or carotid artery 4. Evidence of invasion to surrounding structures, recurrent laryngeal nerve, trachea or carotid artery 5. Extrathyroidal extension 6. Any of N1 or M1 7. Documented increase in size according to America Thyroid Association (ATA) guideline in a previously confirmed Papillary thyroid microcarcinoma 8. \< 18 years 9. Not willing to accept observational active surveillance approach
References
Publications (0)
Data not yet available